GUARDANT HEALTH INC (GH)
US40131M1099 - Common Stock
Overall GH gets a fundamental rating of 3 out of 10. We evaluated GH against 118 industry peers in the Health Care Providers & Services industry. The financial health of GH is average, but there are quite some concerns on its profitability. GH is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
GH had negative earnings in the past year.
In the past year GH has reported a negative cash flow from operations.
In the past 5 years GH always reported negative net income.
In the past 5 years GH always reported negative operating cash flow.
1.2 Ratios
GH has a Return On Assets of -26.84%. This is in the lower half of the industry: GH underperforms 78.63% of its industry peers.
The Return On Equity of GH (-302.14%) is worse than 82.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.84% | ||
| ROE | -302.14% | ||
| ROIC | N/A |
ROA(3y)-28.63%
ROA(5y)-20.99%
ROE(3y)-484.14%
ROE(5y)-296.29%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
GH has a better Gross Margin (59.73%) than 82.91% of its industry peers.
In the last couple of years the Gross Margin of GH has grown nicely.
GH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 59.73% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.1%
GM growth 5Y2.69%
2. Health
2.1 Basic Checks
GH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GH has more shares outstanding
GH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for GH has been reduced compared to a year ago.
2.2 Solvency
GH has an Altman-Z score of -0.79. This is a bad value and indicates that GH is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of GH (-0.79) is worse than 70.09% of its industry peers.
GH has a Debt/Equity ratio of 7.18. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 7.18, GH is not doing good in the industry: 80.34% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.18 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.79 |
ROIC/WACCN/A
WACC7.42%
2.3 Liquidity
A Current Ratio of 6.54 indicates that GH has no problem at all paying its short term obligations.
GH's Current ratio of 6.54 is amongst the best of the industry. GH outperforms 96.58% of its industry peers.
A Quick Ratio of 6.24 indicates that GH has no problem at all paying its short term obligations.
GH's Quick ratio of 6.24 is amongst the best of the industry. GH outperforms 95.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.54 | ||
| Quick Ratio | 6.24 |
3. Growth
3.1 Past
GH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.33%, which is quite impressive.
Looking at the last year, GH shows a very strong growth in Revenue. The Revenue has grown by 25.46%.
Measured over the past years, GH shows a very strong growth in Revenue. The Revenue has been growing by 44.15% on average per year.
EPS 1Y (TTM)32.33%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q37.5%
Revenue 1Y (TTM)25.46%
Revenue growth 3Y25.3%
Revenue growth 5Y44.15%
Revenue growth Q2Q22.19%
3.2 Future
GH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.40% yearly.
Based on estimates for the next years, GH will show a very strong growth in Revenue. The Revenue will grow by 20.34% on average per year.
EPS Next Y8.35%
EPS Next 2Y8.14%
EPS Next 3Y9.43%
EPS Next 5Y19.4%
Revenue Next Year19.03%
Revenue Next 2Y20.35%
Revenue Next 3Y21.71%
Revenue Next 5Y20.34%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for GH. In the last year negative earnings were reported.
Also next year GH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.14%
EPS Next 3Y9.43%
5. Dividend
5.1 Amount
GH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
GUARDANT HEALTH INC
NASDAQ:GH (5/3/2024, 7:00:01 PM)
After market: 18.88 0 (0%)18.88
+0.3 (+1.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.30B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.84% | ||
| ROE | -302.14% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 59.73% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.18 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 6.54 | ||
| Quick Ratio | 6.24 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)32.33%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y8.35%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)25.46%
Revenue growth 3Y25.3%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y